| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000011943 |
| Receipt No. | R000013945 |
| Official scientific title of the study | Evaluation of a point-of-care test kit for the detection of periodontal pathogen in the treatment of periodontal disease: a multi-center study |
| Date of disclosure of the study information | 2015/09/01 |
| Last modified on | 2016/07/14 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Evaluation of a point-of-care test kit for the detection of periodontal pathogen in the treatment of periodontal disease: a multi-center study | |
| Title of the study (Brief title) | Evaluation of a test kit for the detection of periodontal pathogen | |
| Region |
|
|
| Condition | ||
| Condition | Periodontal disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | A point-of-care test kit is used to detect or semi-quantify a major periodontal pathogen, Porphyromonas gingivalis in subgingival plaque samples from patients with periodontitis. Its efficacy in assessing disease severity, decision-making for the use of antimicrobial therapy and evaluating the effect of such therapy will be tested. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1. To compare the results from a commercial test(PCR-Invader) and the present test kit in control and periodontitis groups at baseline.
2. To compare the results from a commercial test and the present test kit before and after SRP (scaling and root planing) and after the use of Periofeel. |
| Key secondary outcomes | The following parameters before SRP, after SRP and after the use of Periofeel.
1)Probing pocket depth 2)Bleeding on probing 3)Clinical attachment level 4)Gingival index 5)Plaque indel 6)Tooth mobility |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -but assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Following SRP, a microbiological assessment using a test kit is performed. Then, minocycline (Periofeel)is locally delivered to positive sites. | ||
| Interventions/Control_2 | Control (Periodontally healthy individuals) | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Periodontitis patients with at least one site with PD 4-5 mm (mild periodontitis).
2. Periodontitis patients with at least one site with PD 6-9 mm (severe periodontitis). 3. Periodontally healthy individuals (control) 4. Those who completed full-mouth scaling before the start of the study (baseline). 5. Those who agreed to participate in the study with written informed consent. |
|||
| Key exclusion criteria | 1. Those with uncontrolled systemic diseases (ex. diabetes, hyperlipidemia, cardiovascular diseases, osteoporosis, autoimmune diseases)
2. Smokers 3. Those with aggressive periodontitis 4. History of antimicrobial treatment within 3 months 5. Those who received SRP within 6 months 6. History of allergic reaction against antimicrobials (especially tetracyclines) |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Hiromasa Yoshie |
| Organization | Niigata University |
| Division name | Division of Periodontology, Niigata University Graduate School of Medical and Dental Sciences |
| Address | 2-5274 Gakkocho-dori, Chuo-ku, Niigata 951-8514, Japan |
| TEL | 025-227-2869 |
| yoshie@dent.niigata-u.ac.jp | |
| Public contact | |
| Name of contact person | Toshiya Morozumi |
| Organization | Niigata University |
| Division name | Division of Periodontology, Niigata University Graduate School of Medical and Dental Sciences |
| Address | 2-5274 Gakkocho-dori, Chuo-ku, Niigata 951-8514, Japan |
| TEL | 025-227-2869 |
| Homepage URL | |
| moro@dent.niigata-u.ac.jp | |
| Sponsor | |
| Institute | Tokyo Dental College
Nihon University School of Dentistry at Matsudo Tsurumi University Niigata University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Showa Yakuhin Kako Co Ltd
Denka Seiken Co Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Showa Yakuhin Kako Co LTD
Denka Seiken Co LTD |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京歯科大学千葉病院(千葉県)
東京歯科大学水道橋病院(東京都) 日本大学松戸歯学部付属病院(千葉県) 鶴見大学歯学部病院(神奈川県) 新潟大学医歯学総合病院(新潟県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | http://www.sciencedirect.com/science/article/pii/S0167701215300129 |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013945 |